189 related articles for article (PubMed ID: 23027047)
1. Engineering small interfering RNAs by strategic chemical modification.
Bramsen JB; Kjems J
Methods Mol Biol; 2013; 942():87-109. PubMed ID: 23027047
[TBL] [Abstract][Full Text] [Related]
2. Chemical modification of small interfering RNA.
Bramsen JB; Kjems J
Methods Mol Biol; 2011; 721():77-103. PubMed ID: 21431680
[TBL] [Abstract][Full Text] [Related]
3. The design, preparation, and evaluation of asymmetric small interfering RNA for specific gene silencing in mammalian cells.
Chang C; Hong SW; Dua P; Kim S; Lee DK
Methods Mol Biol; 2013; 942():135-52. PubMed ID: 23027049
[TBL] [Abstract][Full Text] [Related]
4. Design of nuclease-resistant fork-like small interfering RNA (fsiRNA).
Chernolovskaya EL; Zenkova MA
Methods Mol Biol; 2013; 942():153-68. PubMed ID: 23027050
[TBL] [Abstract][Full Text] [Related]
5. The design, selection, and evaluation of highly specific and functional siRNA incorporating unlocked nucleobase analogs.
Vaish N; Agarwal P
Methods Mol Biol; 2013; 942():111-34. PubMed ID: 23027048
[TBL] [Abstract][Full Text] [Related]
6. Chemical modification of siRNA.
Chernolovskaya EL; Zenkova MA
Curr Opin Mol Ther; 2010 Apr; 12(2):158-67. PubMed ID: 20373259
[TBL] [Abstract][Full Text] [Related]
7. Utilization of unlocked nucleic acid (UNA) to enhance siRNA performance in vitro and in vivo.
Laursen MB; Pakula MM; Gao S; Fluiter K; Mook OR; Baas F; Langklaer N; Wengel SL; Wengel J; Kjems J; Bramsen JB
Mol Biosyst; 2010 May; 6(5):862-70. PubMed ID: 20567772
[TBL] [Abstract][Full Text] [Related]
8. RNA interference in vivo: toward synthetic small inhibitory RNA-based therapeutics.
de Fougerolles A; Manoharan M; Meyers R; Vornlocher HP
Methods Enzymol; 2005; 392():278-96. PubMed ID: 15644187
[TBL] [Abstract][Full Text] [Related]
9. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs.
Aigner A
J Biotechnol; 2006 Jun; 124(1):12-25. PubMed ID: 16413079
[TBL] [Abstract][Full Text] [Related]
10. Improved serum stability and biophysical properties of siRNAs following chemical modifications.
Cho IS; Kim J; Lim DH; Ahn HC; Kim H; Lee KB; Lee YS
Biotechnol Lett; 2008 Nov; 30(11):1901-8. PubMed ID: 18575806
[TBL] [Abstract][Full Text] [Related]
11. The effects of thiophosphate substitutions on native siRNA gene silencing.
Li ZY; Mao H; Kallick DA; Gorenstein DG
Biochem Biophys Res Commun; 2005 Apr; 329(3):1026-30. PubMed ID: 15752758
[TBL] [Abstract][Full Text] [Related]
12. A structure-activity relationship study of siRNAs with structural variations.
Chang CI; Hong SW; Kim S; Lee DK
Biochem Biophys Res Commun; 2007 Aug; 359(4):997-1003. PubMed ID: 17577577
[TBL] [Abstract][Full Text] [Related]
13. Construction of simple and efficient DNA vector-based short hairpin RNA expression systems for specific gene silencing in mammalian cells.
Cheng TL; Chang WT
Methods Mol Biol; 2007; 408():223-41. PubMed ID: 18314586
[TBL] [Abstract][Full Text] [Related]
14. Designing dual-targeting siRNA duplexes having two active strands that combine siRNA and microRNA-like targeting.
Sætrom P
Methods Mol Biol; 2013; 942():169-77. PubMed ID: 23027051
[TBL] [Abstract][Full Text] [Related]
15. Staying on message: design principles for controlling nonspecific responses to siRNA.
Samuel-Abraham S; Leonard JN
FEBS J; 2010 Dec; 277(23):4828-36. PubMed ID: 21078117
[TBL] [Abstract][Full Text] [Related]
16. Effects of conformational alteration induced by D-/L-isonucleoside incorporation in siRNA on their stability in serum and silencing activity.
Huang Y; Chen Z; Chen Y; Zhang H; Zhang Y; Zhao Y; Yang Z; Zhang L
Bioconjug Chem; 2013 Jun; 24(6):951-9. PubMed ID: 23682837
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of 2'-O-guanidinopropyl-modified nucleoside phosphoramidites and their incorporation into siRNAs targeting hepatitis B virus.
Brzezinska J; D'Onofrio J; Buff MC; Hean J; Ely A; Marimani M; Arbuthnot P; Engels JW
Bioorg Med Chem; 2012 Feb; 20(4):1594-606. PubMed ID: 22264759
[TBL] [Abstract][Full Text] [Related]
18. Designing functional siRNA with reduced off-target effects.
Naito Y; Ui-Tei K
Methods Mol Biol; 2013; 942():57-68. PubMed ID: 23027045
[TBL] [Abstract][Full Text] [Related]
19. Structural modification of siRNA for efficient gene silencing.
Lee SJ; Son S; Yhee JY; Choi K; Kwon IC; Kim SH; Kim K
Biotechnol Adv; 2013; 31(5):491-503. PubMed ID: 22985697
[TBL] [Abstract][Full Text] [Related]
20. Improving RNA interference in mammalian cells by 4'-thio-modified small interfering RNA (siRNA): effect on siRNA activity and nuclease stability when used in combination with 2'-O-alkyl modifications.
Dande P; Prakash TP; Sioufi N; Gaus H; Jarres R; Berdeja A; Swayze EE; Griffey RH; Bhat B
J Med Chem; 2006 Mar; 49(5):1624-34. PubMed ID: 16509579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
